Nautilus Biotechnology Reports Third-Quarter 2026 Results
Story updates
10:03:17 AM UTC
SquawkNews
Nautilus Biotechnology 3Q Loss/Shr 12c >NAUT
10:03:26 AM UTC
SquawkNews
Nautilus Biotechnology 3Q Rev $234,000 >NAUT
10:03:37 AM UTC
SquawkNews
Nautilus Biotechnology reported third-quarter 2026 revenue of $234,000 and a net loss of $15.6 million. Operating expenses were $16.9 million, while cash, cash equivalents and investments totaled $114.3 million at September 30, 2026. The company highlighted progress in proteoform assays and its Voy…